Haiying Ding

4PUBLICATIONS
3CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 12, 2025
Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta-Analysis Integrating Randomized Controlled Trials and Prospective Evidence.

Meng-Fei Dai, Gao-Wei Chong, Wen-Xiu Xin

|May 15, 2024
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.

Chaoneng He, Xiufang Mi, Gaoqi Xu

|Jan 24, 2020
Multidisciplinary intervention incorporating pharmacists in management of opioid-naïve patients with moderate to severe cancer pain.

Haiying Ding, Xiaowei Zheng, Sisi Kong

|Jul 05, 2017
Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer.

H Ding, L Fang, W Xin

Pageof 1

Frequent Collaborators

1 joint publications

Meng-Fei Dai

1 joint publications

Gao-Wei Chong

1 joint publications

Wen-Xiu Xin